Women's Health: A Systemic Gap, Not a Niche Issue

Women's health requires fundamental integration into healthcare infrastructure, not siloed treatment. Historically, a lack of inclusion in research meant medical practices were based on male biology, leading to issues like women experiencing nearly twice the adverse drug reactions and being misdiagnosed with conditions like heart attacks. The article highlights the immense cost of such systemic oversights, citing the HRT episode where decades of flawed guidance impacted millions.

Across India and Southeast Asia, this gap is evident in delayed diagnoses for conditions like PCOS and endometriosis, and preventable deaths from cervical cancer due to insufficient screening infrastructure. As Asia invests heavily in healthcare, with its market projected to reach over $5 trillion by 2030, there's a pivotal moment to ensure women's health is designed into new systems.

Implementing gender-disaggregated data, AI trained on diverse datasets, and clinical pathways reflecting female symptom presentation are key. This approach, similar to how curb cuts benefited all, will improve diagnostics and treatments for everyone. Investing in women's health infrastructure is not just a moral imperative but a structural economic opportunity, potentially adding $1 trillion annually to the global economy by 2040.